Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01870752 · ClinicalTrials.gov registry record · NA
Ovarian Tissue Transplantation
A NA study of Infertile Females or Females With Ovarian Insufficiency, sponsored by Abramson Cancer Center at Penn Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT01870752 is a NA study of Infertile Females or Females With Ovarian Insufficiency that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01870752, a NA study of Infertile Females or Females With Ovarian Insufficiency, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Chemotherapy and radiation therapy for the treatment of cancer can compromise fertility. Ovarian tissue cryopreservation is an experimental strategy offered at The University of Pennsylvania to preserve future fertility (protocol 806062). The primary objective of this study is to determine the efficacy and safety of autologous transplantation of previously cryopreserved ovarian cortical tissue in patients who experience infertility or ovarian insufficiency after cancer treatments.
Conditions Studied
Interventions
- PROCEDURE Transplantation of previously cryopreserved ovarian tissu
Study Locations (1)
Pennsylvania
- Abramson Cancer Center of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-06 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01870752
The ClinicalTrials.gov registry entry for NCT01870752 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infertile Females or Females With Ovarian Insufficiency appearing as the primary indexed condition, and to 1 intervention - of which Transplantation of previously cryopreserved ovarian tissu is the first listed.
NCT01870752 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01870752 about?
NCT01870752 is a clinical study titled "Ovarian Tissue Transplantation". Chemotherapy and radiation therapy for the treatment of cancer can compromise fertility. Ovarian tissue cryopreservation is an experimental strategy offered at The University of Pennsylvania to preserve future fertility (protocol 806062). The primary objective of this study is to determine the effic...
What is the current status of trial NCT01870752?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2013-06. Estimated completion is 2028-12.
What conditions does trial NCT01870752 study?
This clinical trial studies the following conditions: Infertile Females or Females With Ovarian Insufficiency.
What interventions are being tested in trial NCT01870752?
The interventions under investigation include: Transplantation of previously cryopreserved ovarian tissu (PROCEDURE).
Who is sponsoring clinical trial NCT01870752?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01870752 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.